GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 91 days ( 24.31 % )
Last Price $3.55 1.14 %
High/ Low $3.50 - $3.55 4.22%
Chg 7 Days 1.87 % $3.49 $3.55
Chg 30 Days -27.10 % $4.87 $3.55
Chg 12 mos 393.06 % $0.720 $3.55
Trend - 3 mos -26.79 % Width: 55.13 %
Trend - 12 mos 176.75 % Width: 252.98 %
Pred. range - 3 mos $1.94 - $3.01 -45.26 % - -15.09 %
Pred. range - 12 mos $6.58 - $23.22 85.28 % - 553.99 %
Short MA avg 3 mos Sell 2023-01-25 - 3 days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2023-01-25 - 3 days
Long MA avg 12 mos Sell 2023-01-05 - 16 days
Short/Long MA avg 12 mos Sell 2023-01-13 - 10 days
Pivot Short Buy 2023-01-26 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD Buy No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT